Physician

Jane Suechung Myung, MD

According to 2025 Medicare claims, Jane Myung, MD (NPI: 1063616472) practices ophthalmology in the Olympia-Lacey-Tumwater, WA market, with the plurality of this provider's patient population coming from Thurston, WA. This provider's primary affiliated billing organization is EYE PHYSICIANS OF OLYMPIA INC PS (NPI: 1821165911; TIN: 910872708) and primary practice location at 98503-1014. Myung is affiliated with the PSW ACO (ACO ID: A5323), participating under the MSSP model.

Myung's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 816 traditional Medicare patients, billed 50,997 HCPCS/CPT codes, and received $2,536,902 in Medicare payments. The top billing code was J0178 (Injection, aflibercept, 1 mg). Part D data shows 336 prescription claims across 112 beneficiaries totaling $17,190 in drug costs, led by Prednisolone Acetate (Prednisolone Acetate). Open Payments data shows 1 records totaling $19. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing has risen steadily, from $235,232 to $2,536,902. Similarly, Part D prescription costs have risen steadily, from $529 to $17,190. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Part B Carrier Billing Trend. X-axis: year 2015-2024. Y-axis: Medicare payment, unit: USD. Field: Tot_Mdcr_Pymt_Amt. Source: Medicare Physician & Other Practitioners by Provider.0$1.6M$3.2M2015 Medicare payment: $235,232 (USD; Tot_Mdcr_Pymt_Amt)2016 Medicare payment: $900,523 (USD; Tot_Mdcr_Pymt_Amt)2017 Medicare payment: $1,294,517 (USD; Tot_Mdcr_Pymt_Amt)2018 Medicare payment: $2,096,832 (USD; Tot_Mdcr_Pymt_Amt)2019 Medicare payment: $2,629,972 (USD; Tot_Mdcr_Pymt_Amt)2020 Medicare payment: $2,921,285 (USD; Tot_Mdcr_Pymt_Amt)2021 Medicare payment: $3,221,701 (USD; Tot_Mdcr_Pymt_Amt)2022 Medicare payment: $3,113,835 (USD; Tot_Mdcr_Pymt_Amt)2023 Medicare payment: $2,792,387 (USD; Tot_Mdcr_Pymt_Amt)2024 Medicare payment: $2,536,902 (USD; Tot_Mdcr_Pymt_Amt)2015201620172018201920202021202220232024
YearPatientsClm LinesPayment
20151961,274$235,232
20164034,189$900,523
20174965,673$1,294,517
20187908,690$2,096,832
201979510,953$2,629,972
202073411,339$2,921,285
202180911,865$3,221,701
202282816,870$3,113,835
202383637,659$2,792,387
202481650,997$2,536,902

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Part D Events Trend. X-axis: year 2015-2024. Y-axis: Drug cost, unit: USD. Field: Tot_Drug_Cst. Source: Medicare Part D Prescribers by Provider.0$9.4K$19K2015 Drug cost: $529 (USD; Tot_Drug_Cst)2016 Drug cost: $4,640 (USD; Tot_Drug_Cst)2017 Drug cost: $4,389 (USD; Tot_Drug_Cst)2018 Drug cost: $11,402 (USD; Tot_Drug_Cst)2019 Drug cost: $14,318 (USD; Tot_Drug_Cst)2020 Drug cost: $17,481 (USD; Tot_Drug_Cst)2021 Drug cost: $18,866 (USD; Tot_Drug_Cst)2022 Drug cost: $15,682 (USD; Tot_Drug_Cst)2023 Drug cost: $14,838 (USD; Tot_Drug_Cst)2024 Drug cost: $17,190 (USD; Tot_Drug_Cst)2015201620172018201920202021202220232024
YearPatientsClaimsDrug Cost
2015N/R19$529
201635100$4,640
20172980$4,389
201870231$11,402
201970229$14,318
202090258$17,481
2021106307$18,866
2022107315$15,682
2023101296$14,838
2024112336$17,190

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

No connected DME records

No connected DME records

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

CodeDescriptionPatientsClm LinesTotal Payment
J0178Injection, aflibercept, 1 mg1501,272$652
99214Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more320468$94
67028Injection of drug into eye3361,581$92
92014Established patient complete exam of visual system566925$87
92134Imaging of retina7982,483$31

Top 5 Part D drugs in 2024

By total drug costs.

DrugGenericClaimsTotal Day SupplyTotal Drug Cost
Prednisolone AcetatePrednisolone Acetate1034,255$5,063
Bromfenac SodiumBromfenac Sodium16305$2,067
Mycophenolate MofetilMycophenolate Mofetil13630$1,496
DifluprednateDifluprednate11590$920
OfloxacinOfloxacin651,455$786

Top 5 DME services in 2024

No connected or detailed DME service-level records for 2024.

Open Payments Summary in 2024

CategoryDefinitionRecordsTotal Reported AmountTop Related Entity
General PaymentsReported payment or transfer-of-value amount.1$19Astellas Pharma US Inc
Research PaymentsReported research-related payment or transfer-of-value amount.0$0N/R
Ownership / Investment InterestsReported value of ownership or investment interests.0$0N/R

FAQ

What Medicare data is available for Jane Suechung Myung, MD?

Tedicare shows public-source Medicare data for Jane Suechung Myung, MD (NPI 1063616472), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Jane Suechung Myung, MD have ACO affiliation data?

Jane Suechung Myung, MD is shown with ACO affiliation data for PSW ACO (MSSP, ACO ID A5323).

What billing organization is linked to Jane Suechung Myung, MD?

Jane Suechung Myung, MD is linked to EYE PHYSICIANS OF OLYMPIA INC PS (billing NPI 1821165911) in the available physician profile data.

Does Jane Suechung Myung, MD have Open Payments data?

Jane Suechung Myung, MD has 1 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.